Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Specimen Handling 118Magnetic Resonance Spectroscopy 115Cyclophosphamide 98pembrolizumab 82Radiotherapy 78Nivolumab 67Cisplatin 64fludarabine 59Biopsy 55Carboplatin 53Standard of Care 45Radiosurgery 43Dexamethasone 40Gemcitabine 39Radiation 37Paclitaxel 36venetoclax 35Rituximab 35Cytarabine 35Bevacizumab 35Surveys and Questionnaires 34Doxorubicin 33fludarabine phosphate 31Temozolomide 31Radiotherapy, Intensity-Modulated 30Capecitabine 30Practice Guidelines as Topic 29Blood Specimen Collection 29Interviews as Topic 28Fluorouracil 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × C188-9 compound × 30 days × Clear all
NCT06141031 2026-05-27

Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma

Washington University School of Medicine

Phase 1 Recruiting
18 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡